Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-03-26 00:00:00 ET · period of report 2026-03-25 · accession 0001610717-26-000137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-03-26 | 2026-03-25 | RVMD | Mancini Anthony | See Remarks | S - Sale+OE | $95.57 | -37.5K | 90.0K | -29% | -$3.58M |
| DT | 2026-03-26 | 2026-03-25 | RVMD | Mancini Anthony | See Remarks | M - OptEx | $33.62 | +37.5K | 91.8K | +69% | +$1.26M |
| DT | 2026-03-26 | 2026-03-25 | RVMD | Mancini Anthony | See Remarks | M - OptEx | $0.00 | -37.5K | 112.3K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-25 | S | D | 400 | $97.21 | 54,400 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $97.12 to $97.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 54,400 Restricted Stock Units. |
| 2 | Common | Common Stock | 2026-03-25 | S | D | 11,036 | $96.43 | 54,800 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $96.00 to $96.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 54,400 Restricted Stock Units. |
| 3 | Common | Common Stock | 2026-03-25 | S | D | 21,086 | $95.49 | 65,836 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $95.00 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 54,400 Restricted Stock Units. |
| 4 | Common | Common Stock | 2026-03-25 | S | D | 3,128 | $94.16 | 86,922 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $93.75 to $94.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 54,400 Restricted Stock Units. |
| 5 | Common | Common Stock | 2026-03-25 | S | D | 1,800 | $93.22 | 90,050 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $92.69 to $93.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 54,400 Restricted Stock Units. |
| 6 | Common | Common Stock | 2026-03-25 | M | A | 37,450 | $33.62 | 91,850 | D | — | — | (F2) Includes 54,400 Restricted Stock Units. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-03-25 | M | D | 37,450 | $0.00 | 112,350 | D | $33.62 · — to 2035-03-31 | 37,450 Common Stock | (F8) Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. |